769
Views
16
CrossRef citations to date
0
Altmetric
Perspective

Should Patients Switched from D to B in the GOLD 2017 Classification be Discontinued from Inhaled Corticosteroids?

, , & ORCID Icon
Pages 465-468 | Received 06 Jun 2017, Accepted 08 Jun 2017, Published online: 26 Jul 2017

Figures & data

Figure 1. Algorithm for ICS withdrawal in COPD patients switched from D to B following GOLD 2017. Footnote: LABA: long-acting β2-agonists; LAMA: long-acting antimuscarinics; ICS: inhaled corticosteroids; BEC: blood eosinophil counts.

Figure 1. Algorithm for ICS withdrawal in COPD patients switched from D to B following GOLD 2017. Footnote: LABA: long-acting β2-agonists; LAMA: long-acting antimuscarinics; ICS: inhaled corticosteroids; BEC: blood eosinophil counts.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.